Show simple item record

dc.rights.licenseCC-BY-NC-ND
dc.contributor.advisorFlinkenflogel, Maarten
dc.contributor.authorKrosveld, E.M.
dc.date.accessioned2010-07-19T17:01:04Z
dc.date.available2010-07-19
dc.date.available2010-07-19T17:01:04Z
dc.date.issued2010
dc.identifier.urihttps://studenttheses.uu.nl/handle/20.500.12932/4742
dc.description.abstractAlzheimer’s Disease (AD) is a neurodegenerative disease, with dementia as the main clinical manifestation. In the search for a disease modifying drug (DMD) against AD, at this time many different companies and institutions are on this same road towards therapeutic intervention. With this Master Thesis, it is tried to map the developmental stages currently used by other institutions/ companies in the search and development for a DMD against AD.
dc.description.sponsorshipUtrecht University
dc.format.extent449957 bytes
dc.format.mimetypeapplication/pdf
dc.language.isoen
dc.titleAlzheimer’s Disease. From Target to Drug - Mapping the Developmental Stages.
dc.type.contentMaster Thesis
dc.rights.accessrightsOpen Access
dc.subject.keywordsAlzheimer, Alzheimer's Disease, Disease Modifying Drug, Crossbeta Biosciences, Elisabeth Krosveld, from target to drug, amyloid beta, patents, review,
dc.subject.courseuuBiology of Disease


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record